Both a drug and its metabolites in the bloodstream are deposited in the follicle of the growing hair.
 - Photo: Psychemedics

Both a drug and its metabolites in the bloodstream are deposited in the follicle of the growing hair.

Photo: Psychemedics

Did the Department of Health and Human Services fail to consult its own drug-testing advisory board when developing new hair-testing guidelines that are expected to be published imminently?

Michael Schaffer is an outgoing board member on the Department of Health and Human Services’ Drug Testing Advisory Board. He is vice president of laboratory operations for Psychemedics Corp., a major hair-testing laboratory, and previously was chief toxicologist at the Cook County Medical Examiner’s Office in Chicago.

In a public statement read aloud at the Sept. 1 meeting of the HHS Drug Testing Advisory Board, Schaffer said he wanted to go on record to address the “fatally flawed process which was used to develop the hair testing guidelines which are about to be published in the Federal Register.”

DTAB has always played a key role in the drafting and revising of federal workplace drug testing guidelines, according to Schaffer, “but that is not what happened with the new hair testing guidelines. DTAB has been cut out of the process entirely. The proposed hair testing guidelines are about to be published and yet I have not even seen a draft of them, much less been asked to provide scientific comment on these guidelines. I believe this is true for the other members of DTAB as well.

“This means that these proposed guidelines were developed without the expertise needed to ensure that they are scientifically accurate and defensible. I fear that these proposed guidelines are going to unnecessarily restrict the use of hair drug testing, an incredibly effective tool at detecting drug use, for reasons which have no scientific basis. If this is the case, it is the health and safety of the public which will suffer.”

He urged the HHS’ Substance Abuse and Mental Health Services Administration to not publish the guidelines until they have undergone DTAB scientific review.

Hair Testing and Trucking Safety

The HHS guidelines are a necessary first step in getting Department of Transportation drug-testing rules for safety-sensitive transportation employees changed to make hair testing an approved method for testing. Currently, only urine testing may be used to meet DOT-required pre-employment, random, and after-crash drug and alcohol testing. The Department of Transportation must formally adopt the HHS hair-testing guidelines before that can change.

SAMHSA has been working on the rule since 2015; Congress ordered HHS to have the rule in place by December 2016.

A report sent to Congress in the summer of 2019 said the reason for a nearly three-year delay was caused by “unresolved scientific issues” such as hair color and potential external contamination of hair that could adversely affect drug test outcomes.

“Addressing the scientific and legal issues associated with hair testing has taken a significant amount of time and is the reason why HHS [Department of Health and Human Services] has not issued hair testing,” the report said.

According to published reports, a proposed rule authorizing the use of hair samples to test truck drivers and other federal workers has been forwarded to the Federal Register for publication soon.

Proponents of hair testing say urine testing misses as many as nine out of 10 “lifestyle” drug users.

The Alliance for Driver Safety & Security, known as The Trucking Alliance, is a major proponent of hair testing and called Schaffer’s “alarming, because it indicates the Trump Administration may propose hair drug test guidelines that discourage employers from using that method, even though it’s 14 times more effective than the DOT urine test for identifying illegal drug abusers,” said Managing Director Lane Kidd.

HDT contacted the media public relations office of the Department of Health and Human Services, as well as Ron Flegel, director of Division of Workplace Programs and the Chairman of DTAB, who referred us to the communication department of HHS’ SAMHSA. We had not received a response before our deadline.

However, according to published reports, Flegel said that once a proposed rule begins the White House Office of Management and Budget review process, its details must be closely held by OMB during the review.

Source link